SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid discussions around Trump's recent actions, including commuting George Santos' sentence, sparking debate and political commentary. The community is actively discussing the implications of these decisions and their broader impact. Some users are expressing discontent with the current political landscape.

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

PJ CRYPTO ($PJ) is trending as community members debate whether it's a buying opportunity or a potential scam. Some investors claim "smart money" is accumulating the token, while others urge caution. The discussion centers on its momentum and potential for future growth within the Solana ecosystem.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation of a potential acquisition or partnership with Incannex ($IXHL), fueled by positive Phase 2 data for a sleep apnea treatment and a shared advisory board member. The community is discussing the strategic implications of this collaboration, including ResMed's potential to co-opt a competitor and expand its product offerings beyond CPAP machines. Option traders are actively trading calls, anticipating a significant move pending further developments.

Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC.

Xylem Inc

XYL is trending as the water technology company garners attention with a series of analyst rating updates and price target revisions. Community discussion also highlights call option activity, with many traders outlining specific strategies with defined entry and exit points. Some investors are also reacting to the company's focus on sustainable solutions and partnerships to tackle global water challenges.

Definitive is an onchain trading platform democratizing advanced trading tools for the masses. Trade any token on any chain with advanced trade order types including Market, Limit Buy/Sell, Stop Loss and TWAP orders.  Route your trade instantly across 100+ DEXs and liquidity pools to get the best prices on every trade. Definitive is built by former Coinbase Institutional trading alumni and active DeFi experts.

Definitive

Definitive (EDGE) is trending amid community excitement around its potential, with some drawing comparisons to early AERO. Bullish sentiment is fueled by its trading platform and anticipation for new developments, as well as speculation around a potential exchange listing. The community is actively discussing price targets and watching for a breakout.

Westinghouse Air Brake Technologies Corp. engages in the provision of equipment, systems, and value-added services for the rail industry. It operates through the Freight and Transit segments. The Freight segment builds new locomotives, manufactures and services components for new and existing freight cars and locomotives, rebuilds freight locomotives, supplies railway electronics, positive train control equipment, and signal design and engineering services, and provides related heat exchange and cooling systems. The Transit segment manufactures and services components for new and existing passenger transit vehicles, including regional trains, high speed trains, subway cars, light-rail vehicles, and buses, builds new commuter locomotives, refurbishes subway cars, and provides heating, ventilation, air conditioning equipment, and doors for buses and subway cars. The company was founded in 1869 and is headquartered in Pittsburgh, PA.

Westinghouse Air Brake Technologies Corp

WAB is trending due to a recent $600 million memorandum with Kazakhstan Temir Zholy for electric shunters and LNG-powered locomotives, highlighting a move towards sustainable rail tech. The community is discussing the company's innovative strides in rail modernization and its potential to reduce emissions. Additionally, positive analyst ratings and increased price targets have spurred interest in WAB's growth prospects.

Equifax, Inc. engages in the provision of information solutions and human resources business process outsourcing services. It operates through the following business segments: U.S. Information Solutions, Workforce Solutions and International. The U.S. Information Solutions segment includes consumer and commercial information services, mortgage loan origination information, financial marketing services, and identity management. The Workforce Solutions segment covers employment, income, and social security number verification services as well as complementary payroll-based transaction and employment tax management services. The International segment offers information, technology, and services to support debt collections and recovery management in Canada, Europe, Latin America and Asia Pacific. The company was founded by Cator Woolford and Guy Woolford in 1899 and is headquartered in Atlanta, GA.

Equifax, Inc.

Equifax ($EFX) is trending due to its strategic moves in the credit scoring market, specifically cutting prices to compete with FICO, sparking community discussion around potential pricing wars and margin impacts. Community members are actively discussing the competitive landscape and Equifax's long-term growth strategy amid regulatory shifts. Upgrades from analysts and new product launches are also contributing to the increased attention on the stock.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending following positive preliminary data from its Farnesyl Transferase Inhibitor (FTI) programs presented at the European Society for Medical Oncology (ESMO) Congress, highlighting the potential of FTIs to enhance clinical activity in treating HRAS-mutant solid tumors and HNSCC with PIK3CA alterations; the community is actively discussing potential price targets and catalysts within the next few months, while also noting the company's strong cash position and strategic partnership.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

BioMarin Pharmaceutical is trending as the community discusses its potential as a buyout candidate, with some analysts projecting significant upside. However, opinions are divided, as some investors express frustration with the stock's performance and cite concerns about competition and pipeline execution. Option activity is high, reflecting both bullish and bearish sentiment.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar and sustainability. The company was founded in 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E Corp is trending amid community discussion around option activity and target prices, with some analysts suggesting the stock is undervalued. Investors are weighing potential opportunities against concerns regarding the utility sector and wildfire liabilities. The conversation also highlights the company's role in supporting data center energy demands and its progress in wildfire safety measures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?

MO's 12% 3-month surge highlights strong earnings, rising smoke-free sales and disciplined execution amid industry weakness.

Altria's Oral Margins Surge to 68.7%: Can the Strength Last?

MO's oral segment OCI margin hits 68.7% as on! pouches boost profitability despite volume dips and rising competition.

Zacks Industry Outlook Highlights Philip Morris International, Altria and Turning Point Brands

Despite declining cigarette sales, Philip Morris International, Altria, and Turning Point Brands are driving growth through smoke-free innovations and shifting consumer trends.

3 Tobacco Stocks to Keep an Eye on Amid Industry Challenges

PM, MO and TPB are navigating declining cigarette sales and rising health awareness through smoke-free innovations and strategic portfolio expansion.

MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?

Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.

Altria Delivers 7.2% EPS Growth in 1H25 Despite Sales Headwinds

MO's first half of 2025 EPS grows 7.2% to $2.67 despite revenue declines, as pricing, efficiency gains and buybacks lifted margins and returns.

Altria Stock Trading at a Discount: What's the Next Best Move?

MO shows steady earnings and strong pricing power, though long-term momentum depends on balancing cigarette declines with smoke-free gains.

Altria Returns $4 Billion to Shareholders in First Half of 2025

MO has returned more than $4 billion to its shareholders in early 2025, fueled by strong dividends, buybacks and a solid balance sheet.

Mo's Smoke-Free Vision vs. Cigarette Declines: Is Transition on Track?

Altria shows cigarette volumes sliding while on! nicotine pouches surge in the second quarter, spotlighting the gradual shift toward smoke-free growth.

The U.S. Food and Drug Administration (FDA) will launch a pilot program on Monday to fast-track reviews of nicotine pouches from four major tobacco companies, aiming to complete assessments by December under pressure from the Trump administration to speed approvals.The program will cover products from Philip Morris International, Altria, Reynolds American, part of British American Tobacco, and Turning Point Brands. Among them are PMI’s Zyn Ultra, Altria’s on! and on! Plus, Reynolds’ Velo mini, and Turning Point’s Fre and Alp, co-owned by former Fox News host Tucker Carlson, Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/us-fda-fast-track-nicotine-pouch-reviews-amid-white-house-pressure-2025-09-08/">reported</a>, citing FDA meeting transcripts.Nicotine pouch approvals have historically taken years. The FDA cleared its first group in January, including 20 Zyn products, more than five years after PMI first&nbsp;submitted its application.&nbsp;The pilot is expected to streamline reviews by focusing only on core product characterization, manufacturing, stability, and abuse-liability data, while increasing communication with companies.Nicotine pouches, placed under the lip, are the fastest-growing U.S. tobacco category, marketed as a lower-risk smoking alternative since they don’t involve inhalation or tobacco. Campaigners warn of youth appeal, while FDA officials say current data does not show significant youth uptake.PMI dominates the market with Zyn, which has posted 40% to 80% U.S. shipment growth every quarter since January 2023. Altria called the FDA’s new approach encouraging for harm reduction, while Turning Point Brands said it reflects a commitment to efficiency.&nbsp;An FDA official said the agency had been pressed by leadership, including the White House, to move faster. Tobacco firms have lobbied President Donald Trump for changes, with BAT’s Reynolds donating $10 million to a pro-Trump super PAC.Yolonda Richardson, CEO of the Campaign for Tobacco-Free Kids, said rigorous review remains essential: “There should be no shortcuts when it comes to our kids’ health.”On Stocktwits, retail sentiment was ‘neutral’ for Philip Morris and Turning Point Brands amid ‘normal’ message volume, while Altria saw ‘bearish’ sentiment with ‘low’ activity.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/PM">Philip Morris</a> shares are up 36.4%,&nbsp;<a href="https://stocktwits.com/symbol/MO">Altria</a> has gained 31.8%, and T<a href="https://stocktwits.com/symbol/TPB">urning Point Brands</a> has jumped 68.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Zyn nicotine pouches are advertised in Warsaw, Poland, April 2, 2025.

FDA To Rush Nicotine Pouch Approvals For Philip Morris, Altria And Turning Point After Trump Pressure

The pilot program will cover products such as PMI’s Zyn Ultra, Altria’s on! Plus, and Turning Point’s Fre, aiming to streamline reviews that previously took years.

Equity

Turning Point Brands, Inc. engages in manufacturing, marketing, and distributing branded consumer products including alternative smoking accessories and consumables with active ingredients. It operates through the following segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions. The Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, and MYO cigar wraps. The Stoker's Products segment manufactures and markets moist snuff and contracts for and markets loose leaf chewing tobacco products. The Creative Distribution Solutions segment markets and distributes liquid nicotine products and other products without tobacco or nicotine, distributes to non-traditional retail outlets via Vapor Beast, and offers products to individual consumers via the VaporFi B2C online platform. The company was founded by Thomas Helms, Jr. in 1988 and is headquartered in Louisville, KY.

Turning Point Brands Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.75	--	--	N/A
Q2 '25	$0.73	$0.79	7.63%	BEAT
Q1 '25	$0.70	$0.79	13.26%	BEAT
Q4 '24	$0.71	$0.13	-81.64%	MISSED
Q3 '24	$0.69	$0.68	-0.97%	MISSED

TPB
Turning Point Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest TPB News

TPBTurning Point Brands Inc